Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Poseida Therapeutics logo

Poseida Therapeutics

Recent Finacing

Series D

Recent Raise

$110M

Poseida Therapeutics is a clinical-stage biopharmaceutical company that develops autologous and allogeneic CAR-T immunotherapies and liver-directed gene therapies using proprietary genome-engineering platforms (piggyBac, Cas-CLOVER, TAL-CLOVER, FFGE).

Founded 2014
California, United States
251-500
Publicly Traded
poseida.com

Highlights

Focus Areas

Biopharma
Biotechnology
Genetics
Therapeutics

Recent Investors

Malin Corporation logo
Vivo Capital logo
Longitude Capital logo
Boxer Capital logo
Perceptive Advisors logo
P
Aisling Capital logo
Novartis Pharma logo
Adage Capital Management logo
Schonfeld Strategic Advisors logo
Fidelity Management & Research Company logo
Tavistock Group logo

Financials

$312.5M

Total Raised

4

Funding rounds

12

Investors


Team

Upgrade to view the team

See the team members at Poseida Therapeutics.